These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 21600112)

  • 1. [The comparative study on high field MRI and pathology of Alzheimer's disease transgenic mice].
    Li MH; Wang PJ; Chen SQ; Zhang W; Gao XL
    Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(13):876-9. PubMed ID: 21600112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative MRI reveals aging-associated T2 changes in mouse models of Alzheimer's disease.
    Falangola MF; Dyakin VV; Lee SP; Bogart A; Babb JS; Duff K; Nixon R; Helpern JA
    NMR Biomed; 2007 May; 20(3):343-51. PubMed ID: 17451178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging.
    Braakman N; Matysik J; van Duinen SG; Verbeek F; Schliebs R; de Groot HJ; Alia A
    J Magn Reson Imaging; 2006 Sep; 24(3):530-6. PubMed ID: 16892201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK; Wengenack TM; Curran GL; Gilles EJ; Poduslo JF
    J Pharmacol Exp Ther; 2007 Aug; 322(2):541-9. PubMed ID: 17505020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deposition of lactoferrin in fibrillar-type senile plaques in the brains of transgenic mouse models of Alzheimer's disease.
    Wang L; Sato H; Zhao S; Tooyama I
    Neurosci Lett; 2010 Sep; 481(3):164-7. PubMed ID: 20599473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice.
    Li S; He H; Cui W; Gu B; Li J; Qi Z; Zhou G; Liang CM; Feng XY
    Anat Rec (Hoboken); 2010 Dec; 293(12):2136-43. PubMed ID: 21089051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.
    Schmitz C; Rutten BP; Pielen A; Schäfer S; Wirths O; Tremp G; Czech C; Blanchard V; Multhaup G; Rezaie P; Korr H; Steinbusch HW; Pradier L; Bayer TA
    Am J Pathol; 2004 Apr; 164(4):1495-502. PubMed ID: 15039236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile.
    Dedeoglu A; Choi JK; Cormier K; Kowall NW; Jenkins BG
    Brain Res; 2004 Jun; 1012(1-2):60-5. PubMed ID: 15158161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia.
    Tong Z; Zhang J; Luo W; Wang W; Li F; Li H; Luo H; Lu J; Zhou J; Wan Y; He R
    Neurobiol Aging; 2011 Jan; 32(1):31-41. PubMed ID: 19879019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-high field 7T MRI: a new tool for studying Alzheimer's disease.
    Kerchner GA
    J Alzheimers Dis; 2011; 26 Suppl 3():91-5. PubMed ID: 21971453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1.
    Ohno M; Chang L; Tseng W; Oakley H; Citron M; Klein WL; Vassar R; Disterhoft JF
    Eur J Neurosci; 2006 Jan; 23(1):251-60. PubMed ID: 16420434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
    Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
    J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
    Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
    Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in cerebral blood volume and amyloid pathology in aged Alzheimer APP/PS1 mice on a docosahexaenoic acid (DHA) diet or cholesterol enriched Typical Western Diet (TWD).
    Hooijmans CR; Rutters F; Dederen PJ; Gambarota G; Veltien A; van Groen T; Broersen LM; Lütjohann D; Heerschap A; Tanila H; Kiliaan AJ
    Neurobiol Dis; 2007 Oct; 28(1):16-29. PubMed ID: 17720508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.